share_log

CGI Inc. (NYSE:GIB) Receives Consensus Rating of "Moderate Buy" From Brokerages

CGI Inc. (NYSE:GIB) Receives Consensus Rating of "Moderate Buy" From Brokerages

CGI Inc.(紐約證券交易所代碼:GIB)獲得券商一致給予的“適度買入”評級
Defense World ·  2022/09/16 02:42

CGI Inc. (NYSE:GIB – Get Rating) (TSE:GIB.A) has received an average rating of "Moderate Buy" from the thirteen ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $125.94.

據MarketBeat.com報道,CGI Inc.(紐約證券交易所代碼:GIB-GET Rating)(多倫多證券交易所代碼:GIB.A)目前覆蓋該公司的13家評級公司的平均評級為“中等買入”。一名分析師對該股的評級為賣出建議,一名分析師發佈了持有建議,五名分析師對該公司發佈了買入建議。在去年發佈了該股報告的經紀商中,平均12個月的價格目標是125.94美元。

GIB has been the subject of several recent research reports. TD Securities lifted their target price on shares of CGI from C$130.00 to C$135.00 in a report on Thursday, July 28th. Canaccord Genuity Group lifted their target price on shares of CGI from C$120.00 to C$125.00 in a report on Thursday, July 28th. StockNews.com downgraded shares of CGI from a "buy" rating to a "hold" rating in a research report on Tuesday, August 9th. Royal Bank of Canada raised their price target on shares of CGI from C$120.00 to C$130.00 in a research report on Thursday, July 28th. Finally, BMO Capital Markets raised their price target on shares of CGI from C$120.00 to C$125.00 in a research report on Thursday, July 28th.

GIB是最近幾份研究報告的主題。道明證券在7月28日週四的一份報告中將中廣核股票的目標價從130.00加元上調至135.00加元。加拿大基因集團在7月28日星期四的一份報告中將中廣核的股票目標價從120.00加元上調至125.00加元。在8月9日週二的一份研究報告中,StockNews.com將CGI的股票評級從買入下調至持有。加拿大皇家銀行在7月28日週四的一份研究報告中將中廣核的目標價從120.00加元上調至130.00加元。最後,蒙特利爾銀行資本市場在7月28日星期四的一份研究報告中將中廣核的股票目標價從120.00加元上調至125.00加元。

Get
到達
CGI
CGI
alerts:
警報:

Institutional Investors Weigh In On CGI

機構投資者參與CGI

A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in CGI by 2.0% in the 1st quarter. Vanguard Group Inc. now owns 7,001,838 shares of the technology company's stock worth $558,957,000 after purchasing an additional 137,002 shares during the period. Mackenzie Financial Corp grew its position in shares of CGI by 21.0% during the 1st quarter. Mackenzie Financial Corp now owns 5,196,311 shares of the technology company's stock valued at $414,597,000 after acquiring an additional 900,529 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of CGI by 3.9% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,372,086 shares of the technology company's stock valued at $348,280,000 after acquiring an additional 162,881 shares during the period. Fiera Capital Corp grew its position in shares of CGI by 9.5% during the 2nd quarter. Fiera Capital Corp now owns 3,638,153 shares of the technology company's stock valued at $289,815,000 after acquiring an additional 316,630 shares during the period. Finally, Bank of Montreal Can grew its position in shares of CGI by 2.8% during the 2nd quarter. Bank of Montreal Can now owns 3,155,706 shares of the technology company's stock valued at $262,221,000 after acquiring an additional 85,922 shares during the period. Institutional investors own 48.92% of the company's stock.

一些大型投資者最近增持或減持了該股。先鋒集團(Vanguard Group Inc.)第一季度在CGI的頭寸增加了2.0%。先鋒集團(Vanguard Group Inc.)在此期間額外購買了137,002股,目前持有這家科技公司7,001,838股股票,價值558,957,000美元。麥肯錫金融公司在第一季度將其在CGI股票的頭寸增加了21.0%。Mackenzie Financial Corp現在擁有這家科技公司5,196,311股股票,價值414,597,000美元,在此期間又購買了900,529股。馬薩諸塞州金融服務公司在第二季度增持了3.9%的CGI股票。馬雲在此期間增持了162,881股,目前持有4,372,086股這家科技公司的股票,價值348,280,000美元。第二季度,Fiera Capital Corp在CGI股票中的頭寸增加了9.5%。Fiera Capital Corp現在擁有這家科技公司3,638,153股股票,價值289,815,000美元,在此期間又購買了316,630股。最後,蒙特利爾銀行在第二季度將其在CGI股票的頭寸增加了2.8%。蒙特利爾銀行在此期間額外收購了85,922股,現在可以擁有3,155,706股這家科技公司的股票,價值262,221,000美元。機構投資者持有該公司48.92%的股份。

CGI Price Performance

CGI性價比

GIB stock opened at $77.80 on Friday. The firm has a 50 day moving average price of $82.83 and a 200-day moving average price of $81.48. CGI has a 52-week low of $73.76 and a 52-week high of $93.93. The firm has a market capitalization of $18.57 billion, a price-to-earnings ratio of 16.66, a PEG ratio of 1.84 and a beta of 0.97. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.82 and a current ratio of 1.12.
GiB股票週五開盤報77.80美元。該公司的50日移動均線價格為82.83美元,200日移動均線價格為81.48美元。CGI的52周低點為73.76美元,52周高點為93.93美元。該公司市值為185.7億美元,市盈率為16.66倍,聚乙二醇率為1.84倍,貝塔係數為0.97。該公司的負債權益比率為0.44,速動比率為0.82,流動比率為1.12。

About CGI

關於CGI

(Get Rating)

(獲取評級)

CGI Inc, together with its subsidiaries, provides information technology (IT) and business process services in Canada; Western, Southern, Central, and Eastern Europe; Australia; Scandinavia; Finland, Poland, and Baltics; the United States; the United Kingdom; and the Asia Pacific. Its services include the management of IT and business outsourcing, systems integration and consulting, and software solutions selling activities.

CGI Inc.及其子公司在加拿大、西歐、南歐、中歐和東歐、澳大利亞、斯堪的納維亞半島、芬蘭、波蘭和波羅的海國家、美國、英國和亞太地區提供信息技術(IT)和業務流程服務。其服務包括IT和業務外包管理、系統集成和諮詢以及軟件解決方案銷售活動。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on CGI (GIB)
  • Is There a Cure for What is Ailing Teladoc Stock?
  • No One Told These 3 Stocks It's a Down Week
  • Why Medical Products Maker Repligen May Be A Potential Buy
  • At 10%, Is Arbor Realty Trust Dividend Worth It?
  • Investors Should Tune Into RF Industries
  • 免費獲取StockNews.com關於CGI的研究報告(GiB)
  • 有什麼辦法可以治癒Teladoc股票的問題嗎?
  • 沒有人告訴這三隻股票這是下跌的一週
  • 為什麼醫療產品製造商Repligen可能成為潛在收購對象
  • 在10%的水平上,Arbor Realty Trust的股息值得嗎?
  • 投資者應關注RF Industries

Receive News & Ratings for CGI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CGI and related companies with MarketBeat.com's FREE daily email newsletter.

接受CGI Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對CGI和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論